Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Recruitment Status: Active, not recruiting"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Active%2C+not+recruiting%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject&page=6
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Active%2C+not+recruiting%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject&page=6
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Recruitment+Status%3A+Active%2C+not+recruiting%22&lookfor=%22Study+Type%3A+Interventional%22&type=Subject&page=6
PubPharm (24.087)
51
Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone : A Randomized Phase II Study Comparing Single-Agent Olaparib, Single Agent Cediranib, and the Combinations of Cediranib/Olaparib, Olaparib/Durvalumab (MEDI4736), Cediranib/Durvalumab (MEDI4736), Olaparib/AZD5363 (Capivasertib) in Women With Recurrent, Persistent or Metastatic Endometrial Cancer.: A Platform Trial for Women With Recurrent or Persistent Endometrial Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
52
Group Antenatal Care: Effectiveness and Contextual Factors Linked to Implementation Success in Malawi : Group Antenatal Care: Effectiveness for Maternal/Infant and HIV Prevention Outcomes and Contextual Factors Linked to Implementation Success in Malawi
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
53
Study of Durvalumab+Olaparib or Durvalumab After Treatment With Durvalumab and Chemotherapy in Patients With Lung Cancer (ORION) : A Phase II Randomized, Multi-Center, Double-Blind, Global Study to Determine the Efficacy and Safety of Durvalumab Plus Olaparib Combination Therapy Compared With Durvalumab Monotherapy as Maintenance Therapy in Patients Whose Disease Has Not Progressed Following Standard of Care Platinum-Based Chemotherapy With Durvalumab in First Line Stage IV Non Small Cell Lung Cancer (ORION)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
54
Response-Adapted Therapy With Copanlisib and Rituximab in Untreated Follicular Lymphoma : A Phase 2 Study of Response-Adapted Therapy With Copanlisib and Rituximab in Untreated Follicular Lymphoma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
55
A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease : Effect of Semaglutide Versus Placebo on the Progression of Renal Impairment in Subjects With Type 2 Diabetes and Chronic Kidney Disease
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
56
Symptom Management Implementation of Patient Reported Outcomes in Oncology : SIMPRO Research Center: Integration and Implementation of PROs for Symptom Management in Oncology Practice
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
57
Pioglitazone for the Treatment of Alcohol Use Disorder : A Randomized Trial of Pioglitazone for the Treatment of Alcohol Use Disorder
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
58
Safety of MB-CART2019.1 in Lymphoma Patients (MB-CART2019.1 Lymphoma / DALY 1) : A Phase I/II Safety, Dose Finding and Feasibility Trial of MB-CART2019.1 in Patients With Relapsed or Resistant CD20 and CD19 Positive B-NHL
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
59
Study of Osimertinib With and Without Ramucirumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) : An Open-Label Randomized Phase II Study of Combining Osimertinib With and Without Ramucirumab in Tyrosine Kinase Inhibitor (TKI)-naïve Epidermal Growth Factor Receptor (EGFR)-Mutant Locally Advanced or Metastatic NSCLC
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
60
A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes : Semaglutide Cardiovascular Outcomes Trial in Patients With Type 2 Diabetes
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
[1]
« Vorheriger
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[2409]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Recruitment Status: Active, not recruiting
Medienart
24.087
Aufsätze
24.087
E-Artikel
24.087
E-Ressourcen
Zeitschriftentitel
20.821
ClinicalTrials.gov
3.266
WHO International Clinical Trials Registry Plat...
Thema
24.087
610
Recruitment Status: Active, not recruiting
24.087
Study Type: Interventional
4.484
Phase: Phase 2
2.848
Phase: Phase 3
2.334
Phase: Phase 1
1.115
Phase: Phase 1, Phase 2
1.098
Phase: Phase 4
1.039
Carcinoma
954
Breast Neoplasms
843
Neoplasms
691
Lymphoma
570
Lung Neoplasms
568
Prostatic Neoplasms
561
Carcinoma, Non-Small-Cell Lung
554
Leukemia
430
Recurrence
415
Multiple Myeloma
396
Syndrome
369
COVID-19
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
23.157
2020-
930
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
24.057
Englisch
30
Unbestimmt
Haven't found what you're looking for?
Wird geladen...